S H Kelkar and Company Limited has informed the Exchange about Sale of entire 17% equity stake of CFF Keva Italy S.p.A. held by the Company to Keva Italy Srl.
SHK · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 0.6 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
S H Kelkar's board has approved the sale of its entire 17% direct equity stake in CFF Keva Italy S.p.A. to Keva Italy Srl, a wholly owned subsidiary of Keva Europe BV, which in turn is a wholly owned subsidiary of S H Kelkar. CFF will become a 100% subsidiary of Keva Italy Srl (and remain part of the Keva Group). CFF contributed Rs. 358.04 Crores in revenue (16.86% of consolidated revenue) and Rs. 94.35 Crores in net worth (7.42% of consolidated net worth) for FY25. The consideration is up to Euro 12.5 million, expected to be completed by September 30, 2026. This is an internal group restructuring to consolidate all European entities under Keva Europe BV, not an outside sale. The transaction is a related party deal done at arm's length.
Since CFF stays within the S H Kelkar group (just moving from direct to indirect holding), there is no real change in business control or consolidation impact for shareholders. Cash inflow of up to ~Rs. 110+ Crores from the internal sale may marginally help the company's liquidity, but the move is largely cosmetic from an investor standpoint.